ALKERMES | Nettoeinkommen



Net Income Veränderung Datum
AbbVie USD 1.29B 1.31B 2025-03
Acadia Pharmaceuticals USD 18.99M 124.76M 2025-03
ALKERMES USD 87.1M 64.63M 2025-06
Amgen USD 1.73B 1.1B 2025-03
Biogen USD 634.8M 394.3M 2025-06
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Eli Lilly USD 2.76B 1.65B 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
Ionis Pharmaceuticals USD 123.55M 270.49M 2025-06
J&J USD 5.54B 5.46B 2025-06
Malin Corporation EUR 0 0 2024-12
Merck USD 4.43B 652M 2025-06
Neurocrine Biosciences USD 107.5M 99.6M 2025-06
Otsuka Holdings JPY 88.53B 3.53B 2025-06
Pfizer USD 2.97B 2.56B 2025-03
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12


ALKERMES Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.